B/BE/21/BVW5 - Information sheet for the public (prepared by the notifier)

File: 
Icône PDF bbe21bvw5_pub_en.pdf
Trial reference: 
A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects With Duchenne Muscular Dystrophy (EMBARK)
Doc type: 
Information for the public